Riskpilot← Back to searchSign inGet full accessOptiksmedjan AB
ABActiveOrg 5567933865Hagby Gård 701Retail sale of medical and orthopaedic goods · NACE 4774Est. 20090 employees
Revenue 2025
SEK 1,1M
-35% vs 2024
EBITDA margin
-55.7%
-1449% vs 2024
Equity ratio
-140.3%
Financial strength
Net profit 2025
SEK -607K
-1110% vs 2024
| Revenue | SEK 1,1M | -35% |
| EBITDA | SEK -607K | -1449% |
| Net profit | SEK -607K | -1110% |
| Total assets | SEK 353K | -59% |
| Equity | SEK -495K | -540% |
| Employees | 0 | — |
Legal name
Optiksmedjan AB
Org number
5567933865
Legal form
Aktiebolag
NACE code
4774 · Retail sale of medical and orthopaedic goods
Founded
11 november 2009
Share capital
SEK 100 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas var för sig av ledamöterna
Company purpose
Bolaget ska bedriva handel med optikvaror, utföra synundersökningar samt därmed förenlig verksamhet.
Address
Hagby Gård 701
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 2 101 | 1 946 | 1 923 | 1 669 | 1 090 |
| Staff expenses | — | — | — | −521 | −616 |
| EBITDA | 39 | −278 | 101 | 45 | −607 |
| Depreciation & amort. | −70 | −91 | −95 | −95 | — |
| EBIT | −31 | −369 | 6 | −50 | −607 |
| Net financials | — | — | — | −0 | −0 |
| Profit before tax | −31 | −370 | 5 | −50 | −607 |
| Tax | −0 | −0 | −0 | — | — |
| Net profit | −31 | −370 | 5 | −50 | −607 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 981 | 1 040 | 1 002 | 867 | 353 |
| Equity | 227 | 157 | 163 | 112 | −495 |
| Long-term debt | 581 | 701 | 668 | 631 | 715 |
| Short-term debt | 173 | 182 | 171 | 124 | 133 |
| Total debt | 754 | 883 | 839 | 755 | 848 |
EBITDA margin
-55.7%
This company
15.8%
Market median
-453% vs market
20212025
Equity ratio
-140.3%
This company
38.2%
Market median
-467% vs market
20212025
Return on equity
-60744900.0%
This company
18.4%
Market median
-330135426% vs market
20212025
Net profit margin
-55.7%
This company
8.1%
Market median
-788% vs market
20212025
Asset turnover
3.09×
This company
1.12×
Market median
+176% vs market
20212025
Debt / equity
1.71×
This company
0.62×
Market median
-176% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
AM Chief Executive Officer | Chief Executive Officer | 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Deputy Board Member | 2024 | |
| Chairman | 2022 | |
| Former (1) | ||
| Deputy Board Member | 2022 – 2024 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Optiksmedjan AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Anna Marie Mia Elisabeth Smedjevik | Chief Executive Officer | 0 companies |
| Anders Oliwer Jonathan Smedjevik | Deputy Board Member | 0 companies |
| Lars Anders Lennart Smedjevik | Chairman | 0 companies |
| Inger Cecilia Marie Persson | Deputy Board Member | 0 companies |